Gene · 1946
EFNA5: ephrin A5
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. EFNA5: ephrin A5. Genes, record 1946. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1946
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P52803 | Ephrin-A5 | 228 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents40
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 5787 | P52803 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1361 | P52803 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1361 | P52803 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 5787 | P52803 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 27680 | P52803 | Espacenet |
| EP 4511052 A2 | 2025-02-26 | 56 | P52803 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 27680 | P52803 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 27680 | P52803 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 27675 | P52803 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 2511 | P52803 | Espacenet |
1 to 10 of 40
See all 40 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,676
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | EFNA5 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 7 | 2025 |
| U24AG021886 | National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | 7 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 6 | 2025 |
| R01EY032056 | Eph-ephrin signaling in the lens | 6 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| ZIAHL006151 | Lysosome biogenesis and homeostasis | 5 | 2025 |
| P20GM121176 | Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2. | 4 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,676Source NIH's project files
See all 1,676 nih grantsPapers1,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A multi-ancestry genome-wide association study of dry eye disease and systemic comorbidities. | EBioMedicine | 2026 | 42790339 | PubTator, text mining | PubMed |
| Spidroin-based nanoparticles derived from spider aggregate gland glue for efficient peptide drug delivery. | J Biotechnol | 2026 | 42749158 | PubTator, text mining | PubMed |
| miR-1289 promotes glioblastoma tumorigenesis via targeting EFNA5. | Brain Res | 2026 | 42692382 | PubTator, text mining | PubMed |
| Comprehensive investigation of hypoxia-associated genes and their predictive significance in osteosarcoma. | Transl Oncol | 2026 | 42322695 | PubTator, text mining | PubMed |
| Identification of EFNA family as new potential prognostic biomarkers correlated with immune cell infiltration in hepatocellular carcinoma. | Transl Cancer Res | 2026 | 42180949 | PubTator, text mining | PubMed |
| Analysis of corneal biomechanical characteristics and clinical correlations in children with dust mite-allergic conjunctivitis. | Sci Rep | 2026 | 41896630 | PubTator, text mining | PubMed |
| Unraveling small non-coding RNAs with a significant post-transcriptional impact on breast cancer cell signaling, using a combinational sequencing approach. | Funct Integr Genomics | 2026 | 41866548 | PubTator, text mining | PubMed |
| Targeted epigenome sequencing of eosinophils reveals CpG sites and regulatory variants associated with asthma. | Genomics | 2026 | 41856296 | PubTator, text mining | PubMed |
| NeuronID: An automatic toolkit for identifying neurons in two-photon calcium imaging data. | PLoS One | 2026 | 41801931 | PubTator, text mining | PubMed |
| Developing a process-oriented classroom observation protocol for assessing high school students' computational thinking in science classrooms: a Rasch-based proficiency framework. | Front Psychol | 2026 | 41797996 | PubTator, text mining | PubMed |
1 to 10 of 1,982
See all 1,982 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1946
GET https://conductscience.org/api/genes/v1/1946/patents?page=2